Evidence map›Paper›PMID 33725175›Full record

Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Prevalence and associated factors of orphan symptoms in advanced cancer patients: a multicenter observational study.

Kaoru Nishijima, Yoshiyuki Kizawa, Toshihiro Yamauchi, Takuya Odagiri, Tetsuya Ito, Keisuke Kaneishi, Keiji Shimizu, Tatsuya Morita, Masanori Mori

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kaoru NishijimaDepartment of Palliative Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunokicho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. knishiji@med.kobe-u.ac.jp.ORCID http://orcid.org/0000-0002-9568-3654
Yoshiyuki KizawaDepartment of Palliative Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunokicho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
Toshihiro YamauchiSeirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Takuya OdagiriDepartment of Palliative Care, Komaki City Hospital, Komaki, Japan.
Tetsuya ItoDepartment of Palliative Care, Japanese Red Cross Medical Center, Tokyo, Japan.
Keisuke KaneishiDepartment of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center, Tokyo, Japan.
Keiji ShimizuDepartment of Palliative Care Internal Medicine, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
Tatsuya MoritaDepartment of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Masanori MoriPalliative Care Team, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Seirei Mikatabara General Hospital · JPKobe University · JPJapanese Red Cross Medical Center · JPKomaki City Hospital · JPTokyo Yamate Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aims of this study were to examine the prevalence of myoclonus, sweating, pruritus, hiccup, and vesical and rectal tenesmus, and to explore associated factors in patients with advanced cancer.

methodsThis multicenter prospective cohort study was conducted in 23 inpatient hospices/palliative care units in Japan from January to December 2017. The prevalence and characteristics of each symptom were assessed on admission and in the 3 days before death. We selected factors that might influence the occurrence of each symptom and investigated the association.

resultsA total of 1896 patients were enrolled. The prevalence of orphan symptoms rose from admission to the 3 days before death: myoclonus 1.3 to 5.3% (95% CI 0.9-1.9%/4.3-6.5%), sweating 1.8 to 4.1% (95% CI 1.3-2.6%/3.1-5.1%), hiccup 1.1 to 1.8% (95% CI 0.7-1.7%/1.2-2.6%), and tenesmus 0.7 to 0.9% (0.4-1.2%/0.5-1.5%). Prevalence of pruritus fell from 3.5 to 2.5% (95% CI 2.7-4.4%/1.8-3.4%). Sweating, pruritus, and hiccups persisted throughout the day in nearly half of the patients. Myoclonus was significantly associated with brain tumors, sweating with opioids and antipsychotics, pruritus with liver and biliary tract cancer, cholestasis and severe diabetes, hiccup with male gender, digestive tract obstruction, severe diabetes, and renal failure. Vesical tenesmus was associated with urinary cancer, antipsychotics, and anticholinergics and rectal tenesmus with pelvic cavity cancer.

conclusionWe found that orphan symptoms occurred in 0.5-5.0% of patients, increased over time except for pruritus, and persisted in half of the patients.

Indexed as

Palliative CarePelvic NeoplasmsAnalgesics, OpioidHumansMalePrevalenceProspective StudiesAnalgesics, OpioidHiccupMyoclonusPalliative carePruritusSweatingTenesmus

Identifiers

PMID33725175
OpenAlexW3137157448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.